Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.36%
SPX
+0.27%
IXIC
+0.79%
FTSE
+0.43%
N225
-0.88%
AXJO
-1.82%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Tonix Pharmaceuticals Advances Clinical Trials for CNS Disorders and Innovative Treatment Solutions

13 days ago
publisher logo
Cashu

Tonix Pharmaceuticals Receives FDA Approval for TNXP Tonmya, New Fibromyalgia Treatment

14 days ago
publisher logo
Cashu

Tonix Pharmaceuticals (TNXP) Gains FDA Approval for New Fibromyalgia Treatment TNXP Tonmya

16 days ago

Key Stats

Market Cap
202.60M
Dividend Yield
0.00%
P/E Ratio
-2.49
EPS
-2197.32
Revenue
10.09M
Avg. Volume
859.80K

About

What does TNXP do?
Tonix Pharmaceuticals Holding, based in Chatham, New Jersey, specializes in developing therapeutics for CNS disorders and immunology, with a portfolio including TNX-102 SL for fibromyalgia and TNX-1500 for autoimmune diseases. Founded in 2010, the company employs 103 people and markets Zembrace SymTouch and Tosymra.
Sector
💻 Health Care
IPO
CEO
Employees
81
Headquarters
New York, USA
Website
http://www.tonixpharma.com
Stocks
Health Care
tnxp
Tonix Pharmaceuticals Holding
NASDAQ: TNXP
-1.99 (0.00%)
27.64
USD
At close at Sep 03, 13:26 UTC
Summary
News
Signals
Benchmarks
Financials